Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The 'DR-EAM' Study - (Type 2) Diabetes Weight Reduction - Evaluation of Appcoaching Model

NCT05626842 is registered in ClinicalTrials.gov with Oviva UK Ltd as lead sponsor.

NCT NCT05626842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05626842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The 'DR-EAM' Study - (Type 2) Diabetes Weight Reduction - Evaluation of Appcoaching Model
Lead sponsor
Oviva UK Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
January 20, 2021
Completion date
September 30, 2023
Enrollment
197 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes